Fig. 3
From: Expression of recombinant HBD3 protein that reduces Mycobacterial infection capacity
Anti-bacterial capacity analysis of rHBD3 protein by E. coli and Staphylococcus. a Anti-bacterial action of different proteins (GST-HBD3, HBD-3, GST, ampicillin) treated on BL21 (DE3) strain. In this experiment, the final concentration of GST tag protein, GST-HBD3 fusion protein, and rHBD3 protein was 20 μg/ml. b Inhibition zone of different protein (GST-HBD3, HBD-3, GST, AMP) on E. coli of BL21 (DE3) stain (W water, G GST tag, GH GST-HBD3 fusion protein, H recombination HBD3 protein, A ampicillin). c Anti-bacterial action of different proteins (GST-HBD3, HBD-3, GST, and AMP) treated on Staphylococcus aureus (ATCC 25923) strain. In this experiment, the concentration of GST tag protein, GST-HBD3 fusion protein, and rHBD3 protein was 10 μg/ml. d Inhibition zone of different proteins (GST-HBD3, HBD-3, GST, and AMP) on S. aureus (ATCC 25923) strain (W water, G GST tag, GH GST-HBD3 fusion protein, H recombination HBD3 protein, A ampicillin)